These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5387904)

  • 1. [Preliminary results of studies of the Scientific Study Committee for the Therapy of Pulmonary Diseases].
    Trendelenburg F
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):141-5. PubMed ID: 5387904
    [No Abstract]   [Full Text] [Related]  

  • 2. [4,4'Diisoamyloxythiocarbanilide (isoxyl) in the therapy of chronic pulmonary tuberculosis resistant to antibiotics and the usual chemotherapeutic agents. (Clinical contribution)].
    Picone A; Di Vincenzo M; Russo C
    G Ital Chemioter; 1965; 12(1):99-106. PubMed ID: 5894082
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of monotherapy with Isoxyl in untreated pulmonary tuberculosis cases of different difficulties and Isoxyl in routine-therapy.
    Kampelmann F
    Antibiot Chemother; 1970; 16():96-104. PubMed ID: 5535617
    [No Abstract]   [Full Text] [Related]  

  • 4. [The resistance of Mycobacterium tuberculosis to ethionamide, thiosemicarbazone and isoxyl and their relations to each other].
    Eule H; Werner E
    Beitr Klin Erforsch Tuberk Lungenkr; 1967; 134(4):247-58. PubMed ID: 4968300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Critical remarks on a clinical test of an antitubercular agent. Experiences with thiocarlide during collective work].
    Mlczoch F; Wildner F
    Prax Pneumol; 1969 Jan; 23(1):1-16. PubMed ID: 4978559
    [No Abstract]   [Full Text] [Related]  

  • 6. A bacteriological study of thiocarlide monotherapy.
    Emerson PA; Lacey BW; Breach MR
    Tubercle; 1969 Sep; 50(3):273-9. PubMed ID: 5388381
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic activity and tolerance of isoxyl in pulmonary tuberculosis].
    Piazza R; Ninni A; Lorenzoni E
    Arch Tisiol Mal Appar Respir; 1966 Oct; 21(10):821-35. PubMed ID: 5300607
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with thiocarlide (Isoxyl).
    Urbancik B
    Antibiot Chemother; 1970; 16():117-23. PubMed ID: 5535608
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of treatment by a combination of thiocarlide and isoniazid in previously untreated pulmonary tuberculosis].
    Aksüğür H; Gülbaran R; Cakirca R
    Poumon Coeur; 1967; 23(6):729-38. PubMed ID: 6070030
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience of Isoxyl treatment.
    Pekkanen PS
    Scand J Respir Dis Suppl; 1968; 63():143-7. PubMed ID: 5188458
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isoniazide-tiocarlide combination or DAT in the treatment of pulmonary tuberculosis. Comparison with isoniazide-PAS combination and especially BPAS].
    Meyer A; Nadjar-Fossé G
    Rev Tuberc Pneumol (Paris); 1968; 32(3):371-80. PubMed ID: 5693998
    [No Abstract]   [Full Text] [Related]  

  • 12. [Initial provisional record of treatment of relapses of active pulmonary tuberculosis with combined rifomycin, ethambutol and thiocarlide].
    Favez G; Willa C
    Acta Tuberc Pneumol Belg; 1969; 60(3):496-500. PubMed ID: 5392721
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trials of D. A. T.(4,4'-di-iso-amyloxy-thio-carbanilide) in common human pulmonary tuberculosis].
    Brouet G; Meeus-Bith L; Pariente R; Névot P
    Rev Tuberc Pneumol (Paris); 1966 Dec; 30(12):1205-20. PubMed ID: 4863945
    [No Abstract]   [Full Text] [Related]  

  • 15. [New experiences with 4-4' diisomayloxythiocarbanilide (D.A.T.C.) in association with other antitubercular drugs in chronic pulmonary tuberculosis].
    Frati HI
    Rev Sanid Milit Argent; 1967; 66(1):71-4. PubMed ID: 5629062
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative results of medium and increased doses of isoniazid in the triple treatment of overt pulmonary tuberculosis].
    Favez G; Maillard JM; Vouilloz M
    Schweiz Med Wochenschr; 1968 Sep; 98(36):1392-5. PubMed ID: 5693896
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin].
    Daddi G
    Wien Med Wochenschr; 1967 Mar; 117(11):266-8. PubMed ID: 5626324
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of use of Isoxyl in various combinations].
    Pregowski W; Zagórecka A
    Przegl Lek; 1967; 23(5):468-71. PubMed ID: 6068644
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect and treatment problems of secondary antitubercular agents].
    Dissmann E
    Wien Med Wochenschr; 1966 Nov; 116(47):996-8. PubMed ID: 6011782
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cooperative controlled trial of thiocarlide (DATC), PAS and bedrest alone in short-term single-drug treatment in retreated cavitary pulmonary tuberculosis].
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 139(2):115-39. PubMed ID: 4888206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.